Skip to main content
SpringerLink
Log in

Role of natural killer cells in control of cancer metastasis

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

There is a close association between levels of natural killer (NK) cell activity and the ability of the host to eliminate circulating tumor cell emboli. Mice that exhibit low levels of NK-cell-mediated cytotoxicity (3-week-old syngeneic mice, 3-week-old allogeneic nude mice, cyclophosphamide- or β-estradiol-treated mice, and beige mice) also exhibit enhanced survival of tumor cells in the vascular bed of the lung and increased incidence of pulmonary tumor metastasis. Conversely, hosts with high NK cell activity (adult nude mice and syngeneic mice treated with NK-cell-stimulating biological response modifiers (BRM)) are very resistant to metastasis. Lymphoid adoptive transfer studies have shown that the effector cell responsible for the antimetastatic activity is the NK cell. In these studies, NK cells were highly effective in destroying circulating tumor cells before their extravasation into the organ parenchyma, whereas they exerted only a minimal inhibiting effect on already established micrometastases. The ability to activate NK cells selectively (without subsequently inducing suppressor macrophages) provides a valuable tool for the evaluation of the role of activated NK cells in therapy of tumor metastasis. The validity of this approach is supported by the finding that NK cells activated by BRM are effective in killing, both in vivo and in vitro, solid tumor cells that developed NK-cell-resistance as a result of adaptive growth in vivo or selection during the metastatic process. An understanding of the mechanisms that regulate NK cell activation or suppression as well as elucidation of the circulatory patterns and anatomical compartmentalization of activated NK cells will help achieve a sustained systemic and/or in situ activation of NK cells which may prove effective in the control of cancer metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fidler IJ, Gersten DM, Hart IR: The biology of cancer invasion and metastasis. Adv Cancer Res 28: 149–250, 1978.

    Google Scholar 

  2. Fidler IJ, Gersten DM, Kripke ML: Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities. Cancer Res 39: 3816–3821, 1979.

    Google Scholar 

  3. Fidder IJ, Gersten DM, Riggs C: Relationship of host immune status to tumor cell arrest, distribution and survival in experimental metastasis. Cancer 40: 46–55, 1977.

    Google Scholar 

  4. Fidler IJ, Kripke ML: tumor cell antigenicity, host immunity and cancer metastasis. Cancer Immunol Immunother 7: 201–205, 1980.

    Google Scholar 

  5. Fidler IJ: Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science 208: 1469–1471, 1980.

    Google Scholar 

  6. Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139–146, 1980.

    Google Scholar 

  7. Hanna N, Fidler IJ: The role of natural killer cells in the destruction of circulating tumor emboli. JNCI 65: 801–809, 1980.

    Google Scholar 

  8. Hanna N, Burton RC: Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J Immunol 127: 1754–1758, 1981.

    Google Scholar 

  9. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR: Role of NK cells in tumor growth and metastasis in beige mice. Nature 284: 622–624, 1980.

    Google Scholar 

  10. Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S: Platelet-tumor cell interaction in mice. The role of platelets in the spread of malignant disease. Int J Cancer 11: 704–718, 1973.

    Google Scholar 

  11. Peterson HI: Fibrinolysis and antifibrinolytic drugs in the growth and spread of tumors. Cancer Treat Rev 4: 213–217, 1977.

    Google Scholar 

  12. Liotta LA, Kleinerman J, Saidel GM: The significance of hematogenous tumor cells clumps in the metastatic process. Cancer Res 36: 889–894, 1976.

    Google Scholar 

  13. Fidler IJ: Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5Iiodo-2′deoxyuridine. J Natl Cancer Inst 45: 733–782, 1970.

    Google Scholar 

  14. Hanna MG: Active specific immunotherapy of residual micrometastases: A comparison of postoperative treatment with BCG-tumor cell vaccine to preoperative intratumoral BCG injection. In: Terry WD, Yamamura Y (eds). Immunobiology and immunotherapy of cancer. Elsevier North-Holland, New York, pp 331–350, 1979.

    Google Scholar 

  15. Kiessling R, Wigzell H: An analysis of the murine NK cells as to the structure, function, and biological relevance. Immunol Rev 44: 165–208, 1979.

    Google Scholar 

  16. Herberman RB, Djeu JR, Kay HD, Ortaldo JR, Riccardi C, Gonnard GD, Holden HT, Fagnani R, Santoni A, Pucetti P: Natural killer cells: Characteristics and regulation of activity. Immunol Rev 44: 43–70, 1979.

    Google Scholar 

  17. Welsh RM: Mouse natural killer cells: Induction, specificity and function. J Immunol 121: 1631–1635, 1978.

    Google Scholar 

  18. Glimcher L, Shen FW, Cantor H: Identification of a cell-surface antigen selectively expressed on the natural killer cell. J Exp Med 145: 1–9, 1977.

    Google Scholar 

  19. Burton RC: Alloantisera selectively reactive with NK cells: Characterization and use in defining NK cell classes. In: Herbermann RB (ed). Natural cell-mediated immunity to tumors. Academic Press, New York, pp 19–36.

  20. Koo GC, Jacobson JB, Hammerling GJ, Hammerling U: Antigenic profile of murine natural killer cells. J Immunol 125: 1003–1006, 1980.

    Google Scholar 

  21. Herberman RB, Ninn ME, Laurin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16: 216–229, 1975.

    Google Scholar 

  22. Keissling R, Klein E, Wigzell H: Natural killer cells in the mouse. a. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5: 112–117, 1975.

    Google Scholar 

  23. Clark EA, Russell PH, Egghart M, Morton MA: Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse. Int J Cancer 24: 688–699, 1979.

    Google Scholar 

  24. Gidlund M, Orn A, Wigzell H, Senik A, Gresser I: Enhanced NK cell activity in mice infected with interferon and interferon inducers. Nature 273: 750–761, 1978.

    Google Scholar 

  25. Djeu JY, Heinbaugh JA, Holden HT, Herberman RB: Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 122: 175–181, 1979.

    Google Scholar 

  26. Wolfe SA, Tracey DE, Henney CS: Induction of ‘natural killer’ cells by BCG. Nature 262: 584–586, 1976.

    Google Scholar 

  27. Ojo E, Haller O, Wigzell H: Corynebacterium parvum-induced peritoneal exudate cells with rapid cytolytic activity against tumor cells are nonphagocytic cells with characteristics of natural killer cells. Scand J Immunol 8: 215–222, 1978.

    Google Scholar 

  28. Henney CS, Juribayashi K, Kern DE, Gillis S: Interleukin-2 augments natural killer cell activity. Nature 291: 335–338, 1981.

    Google Scholar 

  29. Minato N, Reid L, Cantor H, Lengyel P, Bloom B: Mode of regulation of natural killer cell activity by inferferon. J Exp Med 152: 124–137, 1980.

    Google Scholar 

  30. Targan S, Dorey F: Interferon activation of ‘pre-spontaneous killer’ (pre-SK) cells and lateration in kinetics of lysis of both ‘pre-SK’ and active SK cells. J Immunol 124: 2157–2161, 1980.

    Google Scholar 

  31. Mantovani A, Luini W, Peri G, Vecchi A, Spreafico F: Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice. JNCI 61: 1255–1261, 1978.

    Google Scholar 

  32. Seaman WE, Blackman MA, Gindhart TD, Roubinia JR, Loeb JM, Talal N: β-estradiol reduces natural killer cells in mice. J Immunol 121: 2193–2198, 1978.

    Google Scholar 

  33. Haller O, Wigzell H: Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J Immunol 118: 1503–1506, 1977.

    Google Scholar 

  34. Roder J, Duwe A: The beige mutation in the mouse selectively impairs natural killer cell function. Nature 278: 451–453, 1979.

    Google Scholar 

  35. Roder JC, Lohmann-Matthes ML, Domzig W, Wigzell H: The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol 123: 2174–2181, 1979.

    Google Scholar 

  36. Kiessling R, Petranyi G, Klein G, Wigzell H: Genetic variation of in vitro cytolytic activity and in vivo rejection potential of nonimmunized semi-syngeneic mice against a mouse lymphoma line. Int J Cancer 15: 933–940, 1975.

    Google Scholar 

  37. Haller O, Hansson M, Kiessling R, Wigzell H: Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature 270: 609–611, 1977.

    Google Scholar 

  38. Warner NL, Woodruff MFA, Burton RC: Inhibition of the growth of lymphoid tumours in syngeneic athmic (nude) mice. Int J Cancer 20: 146–155, 1977.

    Google Scholar 

  39. Minato N, Bloom BR, Jones C, Holland J, Reid LM: Mechanisms of rejection of virus persistently infected tumor cells by athmic nude mice. J Exp Med 149: 1117–1133, 1979.

    Google Scholar 

  40. Campanile F, Crino L, Bonmassar E, Houchens E, Goldin A: Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice. Cancer Res 37: 394–398, 1977.

    Google Scholar 

  41. Riesenfeld I, Orn A, Gidlund M, Axberg I, Alm GU, Wigzell H: Positive correlation between in vitro NK activity and in vivo resistance towards AKR lymphoma cells. Int J Cancer 25: 399–403, 1980.

    Google Scholar 

  42. Gorelick E, Fogel M, Feldman M, Segal S: Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells. JNCI 63: 1397–1404, 1979.

    Google Scholar 

  43. Karre K, Lein GO, Kiessling R, Klein G, Roder JC: Low natural in vivo resistance to syngeneic leukemias in natural killer-deficient mice. Nature 284: 624–626, 1980.

    Google Scholar 

  44. Salomon JC, Creau-Goldberg N, Lynch NR: Cancer induction by methylcholanthrene and metastatic spread of transplantable tumor in Chediak-Higashi (beige) mice. Cancer Immunol Immunother 8: 67–70, 1980.

    Google Scholar 

  45. Hanna N, Fidler IJ: Relationship between metastatic potential and resistance to natural killer cell-mediated cytotoxicity in three murine tumor systems. JNCI 66: 1183–1190, 1981.

    Google Scholar 

  46. Djeu JY, Heinbaugh JA, Vieira WD, Holden HT, Herberman RB: The effect of immunopharmacoloical agents on mouse natural cell-mediated cytotoxicity and on its augmentation by poly I.C. Immunopharmacology 1: 231–244, 1979.

    Google Scholar 

  47. Steel GG, Adams K: Enhancement by cytotoxic agents of artificial pulmonary metastasis. Br J Cancer 36: 653–658, 1977.

    Google Scholar 

  48. Burton RC, Bartlett SO, Kumar V, Winn HJ: Studies on natural killer (NK) cells: II. Serologic evidence for heterogeneity of murine NK cells. J Immunol 127: 1864–1868, 1981.

    Google Scholar 

  49. de Ruiter J, Cramer SJ, Smink T, van Putten LM: The facilitation of tumor growth in the lung by cyclophosphamide in artifical and spontaneous metastases models. Eur J Cancer 15: 1139–1149, 1979.

    Google Scholar 

  50. Seaman WE, Merigan TC, Talal N: Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon. J Immunol 123: 2903–2905, 1979.

    Google Scholar 

  51. Fidler IJ, Raz A, Fogler WE, Kirsh R, Bugelski P, Poste G: Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res 40: 4460–4466, 1980.

    Google Scholar 

  52. Stutman O, Cuttito MJ: Normal levels of natural cytotoxic cells against solid tumor in NK deficient beige mice. Nature 290: 254–257, 1981.

    Google Scholar 

  53. Klein M, Roder J, Haliotis T, Korec S, Jeth JR, Herberman RB, Katz P, Fauci AS: Chediak-Higashi gene in human. J Exp Med 151: 1049–1058, 1980.

    Google Scholar 

  54. Loutit JF, Towsend KMS, Knowles JF: Tumor surveillance in beige mice. Nature 285: pp 66, 1980.

    Google Scholar 

  55. Dent PB, Fish LA, White LG, Good RA: Chediak-Higashi syndrome. Observations on the nature of the associated malignancy. Lab Invest 15: 1634–1642, 1966.

    Google Scholar 

  56. Blume RS, Wolff SM: The Chediak-Higashi syndrome: studies in four patients and a review of the literature. Medicine 51: 247–280, 1972.

    Google Scholar 

  57. Stutman O, Paige CJ, Figarella EF: Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility. J Immunol 121: 1819–1826, 1978.

    Google Scholar 

  58. Hanna N: Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer 26: 675–680, 1980.

    Google Scholar 

  59. Hanna N: Metastasis of xenogeneic and allogenic tumors in nude mice. In: Liotta L, Hart I (eds). Biology of metastasis. Martinus Nijhoff, The Hague (in press).

  60. Hanna N, Pollack VA, Fidler IJ: The use of young nude mice to study metastasis of human neoplasms. In: Humphrey GB, Dehner LP, Grindey GB, Acton RT (eds) Pediatric oncology. Martinus Nijhoff, The Hague.

  61. Fidler IJ, Caines G, Dolan Z: Survival of hematogenously disseminated allogeneic tumor cells in athymic nude mice. Transplantation 22: 208–212, 1976.

    Google Scholar 

  62. Skov CB, Holland JM, Perkins EH: Development of fewer tumor colonies in lungs of athymic nude mice after intravenous injection of tumor cells. J Natl Cancer Inst 56: 193–195, 1976.

    Google Scholar 

  63. Povlsen CO, Fialkow PJ, Klein G, Rygaard J, Wiener F: Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice. Int J Cancer 11: 30–39, 1973.

    Google Scholar 

  64. Povlsen CO: Heterotransplantation of human malignant melanomas to the mouse mutant nude. Acta Pathol Microbiol Scand [A] 84: 9–14, 1976.

    Google Scholar 

  65. Sordat B, Merenda C, Carrel S: Invasive growth and dissemination of human solid tumors and malignant cell lines grafted subcutaneously to new born nude mice. In: Nomura T, Ohsawa N, Tamaoki N, Fujiware K (eds). Proceedings of the second international workshop on nude mice. University of Tokyo Press, Tokyo, pp 313–326, 1977.

    Google Scholar 

  66. Reid LM, Holland J, Jones C, Wolf B, Sato G: Some of the variables affecting the success of transplantation of human tumors into the athymic nude mouse. In: Houchens DP, Ovejera AA (eds). Proceedings of the symposium on the use of athymic (nude) mice in cancer research. Gustav Fischer Verlag, New York, pp 107–121, 1978.

    Google Scholar 

  67. Hanna N, Fidler IJ: Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice. Cancer Res 41: 438–444, 1981.

    Google Scholar 

  68. Pollack VA, Fidler IJ: The use of young nude mice to select subpopulations of tumor cells with increased metastatic potential from nonsyngeneic neoplasms. JNCI 1982 (in press).

  69. Fidler IJ: Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38: 2651–2660, 1978.

    Google Scholar 

  70. Sugarbaker EV, Ketcham AS: Mechanisms and prevention of cancer dissemination. An overview. Semin Oncol 4: 19–32, 1977.

    Google Scholar 

  71. Weiss L: A pathobiologic overview of metastasis. Semin Oncol 4: 5–17, 1977.

    Google Scholar 

  72. Fogel M, Gorelik E, Segal S, Feldman M: Differences in cell surface antigens of tumor metastases and those of the local tumor. JNCI 62: 585–588, 1979.

    Google Scholar 

  73. Poste G, Nicolson GL: Arrest and metastasis of blood-borne tumors are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77: 399–403, 1980.

    Google Scholar 

  74. Fidler IJ: The relationship of embolic hemogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 9: 223–227, 1973.

    Google Scholar 

  75. Becker S, Klein E: Decreased ‘natural killer’-NK-effect in tumor bearing mice and its relation to the immunity against oncornavirus determined cell surface antigens. Eur J Immunol 6: 892–898, 1976.

    Google Scholar 

  76. Brown JM: A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases. Cancer Res 33: 1217–1224, 1973.

    Google Scholar 

  77. Hoover HC, Jones D, Ketcham AS: The optimal level of anticoagulation for decreasing experimental metastasis. Surgery 79: 625–630, 1976.

    Google Scholar 

  78. Hoover HCJr, Ketcham AS, Millar RC, Gralnick HR: Osteosarcoma: Improved survival with anticoagulation and amputation. Cancer 41: 2475–2480, 1978.

    Google Scholar 

  79. Lotzova E: C. parvum-mediated suppression of the phenomenon of natural killing and its analysis. In: Herberman RB (ed). Natural cell-mediated immunity against tumor. Academic Press, New York, pp 735–752, 1980.

    Google Scholar 

  80. Puccetti P, Santoni A, Riccardi C, Holden H, Herberman RB: Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity. Int J Cancer 24: 819–830, 1979.

    Google Scholar 

  81. Kiessling R, Eriksson E, Hallenbeck LA, Welsh R: A comparative analysis of the cell surface properties of activated vs endogenous mouse natural killer cells. J Immunol 125: 1551–1557, 1980.

    Google Scholar 

  82. Hisano G, Hanna N: Regulatory mechanisms of activation or suppression of murine lymph node natural killer cells. J Natl Cancer Inst, 1982 (in press).

  83. Hanna H: Inhibitation of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res 42: 1337–1342, 1982.

    Google Scholar 

  84. Klimpel GR, Henney CS: BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro. J Immunol 120: 563–569, 1978.

    Google Scholar 

  85. Kirchner H, Glaser M, Herberman RB: Suppression of cell-mediated tumor immunity by Corynebacterium parvum. Nature 251: 396–398, 1975.

    Google Scholar 

  86. Hanna N, Blanc S, Nelken D: Adjuvant-induced nonspecific suppressor cells: In vitro and in vivo studies. Cell Immunol 53: 225–235, 1980.

    Google Scholar 

  87. Nasrallah AG, Gallagher MT, Priest EL, Trentin JJ: Comparative effects of different strains of Corynebacterium parvum on natural cell-mediated cytotoxicity, Cancer Res 40: 4159–4164, 1980.

    Google Scholar 

  88. Ojo E, Haller O, Kimura A, Wigzell H: An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice. Int J Cancer 21: 444–452, 1978.

    Google Scholar 

  89. Savary CA, Lotzova E: Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant and infant mice. J Immunol 120: 239–243, 1978.

    Google Scholar 

  90. Riveros-Moreno V, Niblock A: Analysis of the effect of periodate oxidation and phenol extraction on the antitumor properties of C. parvum. Cancer Immunol Immunother 8: 265–272, 1980.

    Google Scholar 

  91. Becker S, Kiessling R, Lee N, Klein G: Modulation of sensitivity to natural killer cell lysis after in vitro explanation of a mouse lymphoma. J Natl Cancer Inst 61: 1495–1498, 1978.

    Google Scholar 

  92. Tai A, Burton RC, Warner NL: Differential natural killer cell reactivity against T cell lymphomas by cells from normal or stimulated mice. J Immunol 124: 1705–1711, 1980.

    Google Scholar 

  93. Welsch RM, Zinkernagel RM: Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature 268: 646–648, 1977.

    Google Scholar 

  94. Welsh RM, Zinkernagel RM, Hallenbeck LA: Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. II. ‘Specificities’ of the natural killer cells. J Immunol 122: 475–481, 1979.

    Google Scholar 

Download references

Author information

Author notes

  1. Nabil Hanna

    Present address: Department of Immunology, Smith Kline & French Labs, 1500 Spring Garden Street, P.O. Box 7929, 19101, Philadelphia, PA, U.S.A.

Authors and Affiliations

  1. Cancer Metastasis & Treatment Laboratory, NC 1-Frederick Cancer Research Facility, P.O. Box B, 21701, Frederick, MD, U.S.A.

    Nabil Hanna

Authors
  1. Nabil Hanna
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanna, N. Role of natural killer cells in control of cancer metastasis. Cancer Metast Rev 1, 45–64 (1982). https://doi.org/10.1007/BF00049480

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00049480

Keywords

Search

Navigation